These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19276284)

  • 1. Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model.
    Duiker EW; de Vries EG; Mahalingam D; Meersma GJ; Boersma-van Ek W; Hollema H; Lub-de Hooge MN; van Dam GM; Cool RH; Quax WJ; Samali A; van der Zee AG; de Jong S
    Clin Cancer Res; 2009 Mar; 15(6):2048-57. PubMed ID: 19276284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.
    Duiker EW; Meijer A; van der Bilt AR; Meersma GJ; Kooi N; van der Zee AG; de Vries EG; de Jong S
    Br J Cancer; 2011 Apr; 104(8):1278-87. PubMed ID: 21487429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of antitumor properties of rhTRAIL by affinity increase toward its death receptors.
    Reis CR; van der Sloot AM; Szegezdi E; Natoni A; Tur V; Cool RH; Samali A; Serrano L; Quax WJ
    Biochemistry; 2009 Mar; 48(10):2180-91. PubMed ID: 19236007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.
    James MA; Seibel WL; Kupert E; Hu XX; Potharla VY; Anderson MW
    Anticancer Drugs; 2015 Jun; 26(5):518-30. PubMed ID: 25646742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.
    Heijink DM; Jalving M; Oosterhuis D; Sloots IA; Koster R; Hollema H; Kleibeuker JH; Koornstra JJ; de Vries EG; de Jong S
    J Pathol; 2011 Feb; 223(3):378-89. PubMed ID: 21171083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL.
    Meijer A; Kruyt FA; van der Zee AG; Hollema H; Le P; ten Hoor KA; Groothuis GM; Quax WJ; de Vries EG; de Jong S
    Br J Cancer; 2013 Nov; 109(10):2685-95. PubMed ID: 24136147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
    Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
    Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
    Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of recombinant human tumor-necrosis factor related to apoptosis inducing ligand protein on apoptosis of human lung adenocarcinoma cell line resistant to cisplatin].
    Zhang M; Hu C; Chen Q; Yang H
    Zhongguo Fei Ai Za Zhi; 2005 Oct; 8(5):419-23. PubMed ID: 21205524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumoricidal activity of combining the agonistic DR5 antibody D-6 with cisplatin in C30 cisplatin-resistant ovarian cancer in vitro and in vivo.
    Huang Y; Liang B; Jiang Q; Chen C; Yang K; Li C; Zheng A
    Mol Med Rep; 2014 Jul; 10(1):183-90. PubMed ID: 24789319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
    Hougardy BM; Maduro JH; van der Zee AG; de Groot DJ; van den Heuvel FA; de Vries EG; de Jong S
    Int J Cancer; 2006 Apr; 118(8):1892-900. PubMed ID: 16287099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHM-1 induces apoptosis via p38-mediated upregulation of DR5 expression in human ovarian cancer SKOV3 cells.
    Lee JC; Chou LC; Huang CH; Chung JG; Huang LJ; Lee KH; Hung MC; Way TD; Kuo SC
    Eur J Pharmacol; 2011 Nov; 670(1):96-104. PubMed ID: 21907193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of naive and radiolabeled rhTRAIL on the cervical cancer xenografts in mice.
    Wang XG; Jandl T; Dadachova E; Revskaya E
    Ther Deliv; 2014 Feb; 5(2):139-47. PubMed ID: 24483193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
    Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo.
    Fan QL; Zou WY; Song LH; Wei W
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):189-96. PubMed ID: 15290100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway.
    Shamimi-Noori S; Yeow WS; Ziauddin MF; Xin H; Tran TL; Xie J; Loehfelm A; Patel P; Yang J; Schrump DS; Fang BL; Nguyen DM
    Cancer Gene Ther; 2008 Jun; 15(6):356-70. PubMed ID: 18309355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells.
    Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W
    Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells.
    Woods DC; Alvarez C; Johnson AL
    Gynecol Oncol; 2008 Mar; 108(3):632-40. PubMed ID: 18191995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.